Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study.

Saved in:
Bibliographic Details
Title: Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study.
Authors: Xie SH; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China., Yang LT; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China.; Department of Thoracic Surgery, Baoji Traditional Chinese Medicine Hospital, Baoji, Shaanxi, China., Zhang H; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China.; Department of Thoracic Surgery, Gaozhou People's Hospital, Gaozhou, Guangdong, China., Tang ZL; Department of Thoracic Surgery, Quanzhou First Hospital, Quanzhou, Fujian, China.; Department of Thoracic Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China., Lin ZW; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China., Chen Y; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; The Graduate School of Fujian Medical University, Fuzhou, Fujian, China., Hong ZN; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, Fujian, China.; Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, Fujian, China., Xu RY; Department of Thoracic Surgery, Quanzhou First Hospital, Quanzhou, Fujian, China.; Department of Thoracic Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China., Lin WL; Department of Thoracic Surgery, Gaozhou People's Hospital, Gaozhou, Guangdong, China., Kang MQ; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, Fujian, China.; Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, Fujian, China.
Source: Frontiers in immunology [Front Immunol] 2024 Feb 05; Vol. 15, pp. 1332492. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).
Publication Type: Multicenter Study; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2024.1332492